SS
WST icon

Sunbelt Securities’s West Pharmaceutical WST Stock Holding History

Sunbelt Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$2.48K – 3092
2025
Q4 		$2.48K Hold
9
– – ﹤0.01% 1830
2025
Q3 		$2.36K Buy
+9
New +$2.19K ﹤0.01% 1820
2024
Q3 		– Sell
-14
Closed -$4.61K – 1909
2024
Q2 		$4.61K Hold
14
– – ﹤0.01% 1416
2024
Q1 		$5.54K Sell
14
-41
-75% -$15.2K ﹤0.01% 1347
2023
Q4 		$19.4K Sell
55
-27
-33% -$9.55K ﹤0.01% 1041
2023
Q3 		$30.8K Sell
82
-8
-9% -$3.09K ﹤0.01% 911
2023
Q2 		$34.4K Buy
90
+17
+23% +$6.07K 0.01% 877
2023
Q1 		$24.9K Buy
+73
New +$21.3K ﹤0.01% 899
2022
Q3 		– Sell
-716
Closed -$216K – 457
2022
Q2 		$216K Sell
716
-5
-0.7% -$1.63K 0.05% 395
2022
Q1 		$302K Buy
721
+39
+6% +$15.3K 0.06% 354
2021
Q4 		$273K Buy
+682
New +$294K 0.04% 393

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sunbelt Securities's WST Position: Q1 2026 in Review

Sunbelt Securities sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 9 shares — an estimated $2.48K sold.

Sunbelt Securities first reported a position in WST in Q4 2021 and held it in 11 quarters. The position peaked at $302K in Q1 2022. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Sunbelt Securities reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Sunbelt Securities sold 9 West Pharmaceutical shares in Q1 2026, an estimated $2.48K.
  • Sunbelt Securities first reported a position in West Pharmaceutical in Q4 2021 and held it in 11 quarters.
  • Sunbelt Securities's West Pharmaceutical position peaked at $302K in Q1 2022.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.